| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Five-Year Outcomes From the Randomized, Phase 3 Trials CheckMate 017/057: Nivolumab vs Docetaxel in Previously Treated NSCLC |
| Type de publication | Journal Article |
| Year of Publication | 2019 |
| Auteurs | Gettinger S., Borghaei H., Brahmer J., Chow L., Burgio M., J. Carpeno DCastro, Pluzanski A., Arrieta O., O. Frontera A, Chiari R., Butts C., Wojcik-Tomaszewska J., Coudert B., Garassino M., Ready N., Felip E., M. Garcia A, Waterhouse D., Domine M., Barlesi F., Antonia S., Wohlleber M., Gerber D., Czyzewicz G., Spigel D., Crino L., Eberhardt W., Li A., Marimuthu S., Vokes E. |
| Journal | JOURNAL OF THORACIC ONCOLOGY |
| Volume | 14 |
| Pagination | S244-S245 |
| Date Published | OCT |
| Type of Article | Meeting Abstract |
| ISSN | 1556-0864 |
| Mots-clés | 5-year overall survival, advanced non-small cell lung cancer, nivolumab |
| DOI | 10.1016/j.jtho.2019.08.486 |
